• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Stocks That Hit 52-Week Lows On Friday

    11/11/22 12:07:49 PM ET
    $ACEV
    $ACST
    $ADIL
    $AGRI
    Semiconductors
    Technology
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ACEV alert in real time by email

     

    On Friday, 63 stocks hit new 52-week lows.

    Interesting Points From Today's 52-Week Lows:

    • Algonquin Power (NYSE:AQN) was the biggest company in terms of market cap to set a new 52-week low.
    • The smallest company on a market cap basis to set a new 52-week low was First Wave BioPharma (NASDAQ:FWBI).
    • Blue Apron Hldgs (NYSE:APRN)'s stock came under the most pressure, trading down 29.9% to reach a new 52-week low.
    • Cardio Diagnostics Hldgs (NASDAQ:CDIO) shares were the most resilient, as shares rose 0.0%, rebounding from its new 52-week low.

    The stocks that set new 52-week lows on Friday:

    • Algonquin Power (NYSE:AQN) shares hit a yearly low of $9.28. The stock was down 14.9% on the session.
    • Agiliti (NYSE:AGTI) shares moved down 5.68% on Friday to hit a new 52-week low of $14.20, drifting down 5.68%.
    • EverCommerce (NASDAQ:EVCM) stock hit a yearly low of $6.01. The stock was down 20.72% for the day.
    • FIGS (NYSE:FIGS) shares reached a new 52-week low of $5.55 on Friday morning, moving down 2.59%.
    • Expensify (NASDAQ:EXFY) shares were down 21.0% for the day, having made a 52-week low of $8.61.
    • Arco Platform (NASDAQ:ARCE) stock achieved a new 52-week low on Friday morning, hitting $9.84 and moving down 4.1%.
    • Trevena (NASDAQ:TRVN) stock achieved a new 52-week low on Friday morning, hitting $2.38 and moving up 0.81%.
    • SoundHound AI (NASDAQ:SOUN) shares made a new 52-week low of $1.77 on Friday. The stock was down 0.45% for the day.
    • Largo (NASDAQ:LGO) shares reached a new 52-week low of $4.84 on Friday morning, moving up 3.47%.
    • Tattooed Chef (NASDAQ:TTCF) shares fell to $3.22 on Friday, setting a new 52-week low with a shift of down 15.47%.
    • Global Business Travel (NYSE:GBTG) shares fell to $4.90 on Friday, setting a new 52-week low with a shift of down 7.09%.
    • Arbe Robotics (NASDAQ:ARBE) stock broke to a new 52-week low of $4.18 on Friday. Shares of the company traded down 0.23%.
    • Tritium DCFC (NASDAQ:DCFC) stock broke to a new 52-week low of $1.57 on Friday. Shares of the company traded up 1.86%.
    • The Oncology Institute (NASDAQ:TOI) stock set a new 52-week low of $2.45 on Friday, moving down 12.07%.
    • AirSculpt Technologies (NASDAQ:AIRS) stock hit a new 52-week low of $3.23. The stock was down 29.28% on the session.
    • Rallybio (NASDAQ:RLYB) shares reached a new 52-week low of $4.86 on Friday morning, moving down 18.51%.
    • Bitfarms (NASDAQ:BITF) shares reached a new 52-week low of $0.68 on Friday morning, moving up 1.18%.
    • Science 37 Hldgs (NASDAQ:SNCE) shares set a new 52-week low of $0.82. The stock traded down 21.6%.
    • ACE Convergence Acq (NASDAQ:ACEV) shares set a new 52-week low of $8.90. The stock traded down 1.26%.
    • Kaixin Auto Hldgs (NASDAQ:KXIN) stock hit a yearly low of $0.43. The stock was down 6.08% for the day.
    • ThredUp (NASDAQ:TDUP) stock hit $0.73 on Friday morning, setting a new 52-week low for a change of up 4.47%.
    • Jounce Therapeutics (NASDAQ:JNCE) shares set a new 52-week low of $1.11. The stock traded up 5.98%.
    • XWELL (NASDAQ:XWEL) shares made a new 52-week low of $0.54 on Friday. The stock was up 1.18% for the day.
    • East Stone Acq (NASDAQ:ESSC) shares reached a new 52-week low of $6.99 on Friday morning, moving down 29.56%.
    • Pyxis Oncology (NASDAQ:PYXS) stock hit a yearly low of $1.38. The stock was down 2.82% for the day.
    • Blue Apron Hldgs (NYSE:APRN) shares set a new 52-week low of $1.17. The stock traded down 29.9%.
    • BioLine Rx (NASDAQ:BLRX) shares hit a yearly low of $0.57. The stock was up 0.48% on the session.
    • Redhill Biopharma (NASDAQ:RDHL) shares set a new 52-week low of $0.45. The stock traded down 17.55%.
    • LightPath Technologies (NASDAQ:LPTH) shares fell to $0.99 on Friday, setting a new 52-week low with a shift of up 5.88%.
    • Aprea Therapeutics (NASDAQ:APRE) shares set a new 52-week low of $0.41. The stock traded down 16.67%.
    • Acasti Pharma (NASDAQ:ACST) shares set a new yearly low of $0.48 this morning. The stock was down 1.77% on the session.
    • China Natural Resources (NASDAQ:CHNR) shares set a new yearly low of $0.42 this morning. The stock was down 1.88% on the session.
    • Cardio Diagnostics Hldgs (NASDAQ:CDIO) shares were 0.0% (flat) for the day, having made a 52-week low of $1.68.
    • Vapotherm (NYSE:VAPO) shares were up 0.15% for the day, having made a 52-week low of $0.58.
    • AgriFORCE Growing Systems (NASDAQ:AGRI) shares set a new 52-week low of $0.95. The stock traded up 2.01%.
    • PLx Pharma (NASDAQ:PLXP) stock hit a new 52-week low of $0.41. The stock was down 23.33% on the session.
    • Venus Concept (NASDAQ:VERO) shares moved down 4.06% on Friday to hit a new 52-week low of $0.20, drifting down 4.06%.
    • Reed's (NASDAQ:REED) stock hit $0.11 on Friday morning, setting a new 52-week low for a change of down 7.03%.
    • NexImmune (NASDAQ:NEXI) stock broke to a new 52-week low of $0.48 on Friday. Shares of the company traded 0.0% (flat).
    • BIO-key Intl (NASDAQ:BKYI) stock hit $1.34 on Friday morning, setting a new 52-week low for a change of down 2.37%.
    • Kazia Therapeutics (NASDAQ:KZIA) shares hit a yearly low of $0.65. The stock was up 0.01% on the session.
    • Ayala Pharmaceuticals (NASDAQ:AYLA) stock achieved a new 52-week low on Friday morning, hitting $0.55 and moving up 0.33%.
    • Arcadia Biosciences (NASDAQ:RKDA) shares hit a yearly low of $0.30. The stock was down 5.75% on the session.
    • OncoSec Medical (NASDAQ:ONCS) stock achieved a new 52-week low on Friday morning, hitting $3.96 and moving down 12.02%.
    • Phio Pharma (NASDAQ:PHIO) shares reached a new 52-week low of $0.51 on Friday morning, moving down 1.87%.
    • Trxade Health (NASDAQ:MEDS) shares set a new 52-week low of $0.70. The stock traded up 7.19%.
    • Adial Pharmaceuticals (NASDAQ:ADIL) stock broke to a new 52-week low of $0.24 on Friday. Shares of the company traded up 0.56%.
    • Kintara Therapeutics (NASDAQ:KTRA) shares fell to $0.08 on Friday, setting a new 52-week low with a shift of down 18.54%.
    • Healthcare Triangle (NASDAQ:HCTI) stock hit $0.16 on Friday morning, setting a new 52-week low for a change of down 8.15%.
    • NeuBase Therapeutics (NASDAQ:NBSE) shares moved down 1.06% on Friday to hit a new 52-week low of $0.18, drifting down 1.06%.
    • Quotient (NASDAQ:QTNT) stock broke to a new 52-week low of $1.54 on Friday. Shares of the company traded down 10.9%.
    • Viveve Medical (NASDAQ:VIVE) stock dropped to a yearly low on Friday of $0.47. Shares traded down 6.65%.
    • Cuentas (NASDAQ:CUEN) shares reached a new 52-week low of $0.30 on Friday morning, moving down 5.0%.
    • Schmitt Industries (NASDAQ:SMIT) stock hit a new 52-week low of $0.81. The stock was down 10.2% on the session.
    • Energy Focus (NASDAQ:EFOI) stock drifted down 4.38% on Friday morning to hit a new 52-week low of $0.32.
    • First Wave BioPharma (NASDAQ:FWBI) shares reached a new 52-week low of $0.85 on Friday morning, moving 0.0% (flat).

    Be sure to monitor Benzinga for the news traders need! And for even more up-to-date info on 52-week lows and highs, check out Benzinga Pro. This cutting-edge market research platform alerts traders of which stocks are trading near their 52-week highs and lows each morning - and delivers lots of other actionable data. Learn more here.

    Get the next $ACEV alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACEV
    $ACST
    $ADIL
    $AGRI

    CompanyDatePrice TargetRatingAnalyst
    Kazia Therapeutics Limited
    $KZIA
    4/15/2026$25.00Buy
    Laidlaw
    Global Business Travel Group Inc.
    $GBTG
    4/7/2026$6.50Neutral
    BofA Securities
    ThredUp Inc.
    $TDUP
    4/6/2026$5.00Buy
    TD Cowen
    Algonquin Power & Utilities Corp.
    $AQN
    4/1/2026$7.00Overweight
    Barclays
    FIGS Inc.
    $FIGS
    3/20/2026$22.00Perform → Outperform
    Oppenheimer
    EverCommerce Inc.
    $EVCM
    3/13/2026Mkt Outperform → Mkt Perform
    Citizens
    Algonquin Power & Utilities Corp.
    $AQN
    3/9/2026$7.25Mkt Perform → Outperform
    Raymond James
    Algonquin Power & Utilities Corp.
    $AQN
    3/9/2026$6.50 → $6.00Hold
    TD Cowen
    More analyst ratings

    $ACEV
    $ACST
    $ADIL
    $AGRI
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for APHEXDA issued to BIOLINERX, LTD.

    Submission status for BIOLINERX, LTD.'s drug APHEXDA (ORIG-1) with active ingredient MOTIXAFORTIDE has changed to 'Approval' on 09/08/2023. Application Category: NDA, Application Number: 217159, Application Classification: Type 1 - New Molecular Entity

    9/11/23 2:15:50 PM ET
    $BLRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACEV
    $ACST
    $ADIL
    $AGRI
    SEC Filings

    View All

    SEC Form S-8 filed by Arbe Robotics Ltd.

    S-8 - Arbe Robotics Ltd. (0001861841) (Filer)

    4/23/26 5:22:16 PM ET
    $ARBE
    EDP Services
    Technology

    SEC Form DEFA14A filed by FIGS Inc.

    DEFA14A - FIGS, Inc. (0001846576) (Filer)

    4/23/26 4:17:16 PM ET
    $FIGS
    Apparel
    Consumer Discretionary

    SEC Form DEF 14A filed by FIGS Inc.

    DEF 14A - FIGS, Inc. (0001846576) (Filer)

    4/23/26 4:11:10 PM ET
    $FIGS
    Apparel
    Consumer Discretionary

    $ACEV
    $ACST
    $ADIL
    $AGRI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Laidlaw initiated coverage on Kazia Therapeutics with a new price target

    Laidlaw initiated coverage of Kazia Therapeutics with a rating of Buy and set a new price target of $25.00

    4/15/26 8:09:21 AM ET
    $KZIA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    BofA Securities initiated coverage on Global Business Travel Group with a new price target

    BofA Securities initiated coverage of Global Business Travel Group with a rating of Neutral and set a new price target of $6.50

    4/7/26 8:47:13 AM ET
    $GBTG
    Transportation Services
    Consumer Discretionary

    TD Cowen initiated coverage on thredUP with a new price target

    TD Cowen initiated coverage of thredUP with a rating of Buy and set a new price target of $5.00

    4/6/26 8:45:54 AM ET
    $TDUP
    Catalog/Specialty Distribution
    Consumer Discretionary

    $ACEV
    $ACST
    $ADIL
    $AGRI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Chief Administrative Officer England Kristin

    4 - Oncology Institute, Inc. (0001799191) (Issuer)

    4/23/26 9:25:46 PM ET
    $TOI
    Medical/Nursing Services
    Health Care

    SEC Form 4 filed by Chief Clinical Officer Langsam Jeffrey

    4 - Oncology Institute, Inc. (0001799191) (Issuer)

    4/23/26 9:24:23 PM ET
    $TOI
    Medical/Nursing Services
    Health Care

    Chief Executive Officer Remer Eric Richard sold $228,734 worth of shares (19,200 units at $11.91) as part of a pre-agreed trading plan, decreasing direct ownership by 0.65% to 2,934,123 units (SEC Form 4)

    4 - EverCommerce Inc. (0001853145) (Issuer)

    4/23/26 4:19:41 PM ET
    $EVCM
    Computer Software: Prepackaged Software
    Technology

    $ACEV
    $ACST
    $ADIL
    $AGRI
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Chernett Jorey bought $1,225,101 worth of shares (398,985 units at $3.07), increasing direct ownership by 4% to 10,251,929 units (SEC Form 4)

    4 - Oncology Institute, Inc. (0001799191) (Issuer)

    3/17/26 7:40:00 PM ET
    $TOI
    Medical/Nursing Services
    Health Care

    Large owner Chernett Jorey bought $257,211 worth of shares (105,848 units at $2.43), increasing direct ownership by 2% to 6,592,059 units (SEC Form 4)

    4 - Airsculpt Technologies, Inc. (0001870940) (Issuer)

    3/16/26 6:43:51 PM ET
    $AIRS
    Medical/Nursing Services
    Health Care

    Director Nakache Patricia bought $49,076 worth of shares (13,157 units at $3.73) (SEC Form 4)

    4 - ThredUp Inc. (0001484778) (Issuer)

    3/10/26 6:24:14 PM ET
    $TDUP
    Catalog/Specialty Distribution
    Consumer Discretionary

    $ACEV
    $ACST
    $ADIL
    $AGRI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Expensify to Announce Q1 2026 Results

    Join Expensify's earnings call on Thursday, May 7th at 2pm PT / 5pm ET. Expensify, Inc. (NASDAQ:EXFY), the easiest way to manage expenses, corporate cards, and travel, today announced that the company's Q1 2026 financial results will be released after market close on Thursday, May 7th, 2026. Expensify will host a call to discuss its Q1 2026 results on Thursday, May 7th, 2026 at 2pm PT / 5pm ET. The link to the call will be available that day on the company's Investor Relations website at investors.expensify.com. Prior to the call, interested parties can visit the website to add the event to their calendars. After the call, the following will be made available at investors.expensify.co

    4/23/26 4:00:00 PM ET
    $EXFY
    Computer Software: Prepackaged Software
    Technology

    Casey's Expands Partnership with SoundHound AI, Leveraging Cutting-Edge AI Agents Across More Than 2600 Stores

    SANTA CLARA, Calif., April 23, 2026 (GLOBE NEWSWIRE) --  SoundHound AI, Inc. (NASDAQ:SOUN), a global leader in voice and conversational AI, today announced the renewal and expansion of its long-standing partnership with Casey's, the third-largest convenience retailer in the United States. The expanded deal highlights the strength of the collaboration, as SoundHound's AI-powered ordering agents have already supported Casey's in handling more than 21 million guest interactions, successfully processing millions of food orders. Casey's has deployed the technology across more than 2,600 locations, helping ensure guests can place orders quickly and easily. Casey's is focused on delivering co

    4/23/26 9:04:00 AM ET
    $CASY
    $SOUN
    Retail-Auto Dealers and Gas Stations
    Consumer Discretionary
    Computer Software: Prepackaged Software
    Technology

    Cuentas Inc. Reports 2025 Strategic Transformation, Cuts Annual Net Loss by more than 50%, Streamlines Legacy Liabilities, and Expands World Mobile Alliance

    Miami Beach, FL, April 23, 2026 (GLOBE NEWSWIRE) -- Cuentas Inc. (OTCQB:CUEN) today announced a pivotal year of strategic transformation in connection with its Annual Report on Form 10-K for the year ended December 31, 2025, highlighted by a reduction in annual net loss of 52.5%, significant progress in resolving legacy liabilities, and continued expansion of its high-potential alliance with World Mobile Group Ltd. During 2025, Cuentas sharpened its focus around its mobile communications platform and executed a series of transactions designed to strengthen its operating foundation, simplify its balance sheet, and accelerate long-term strategic positioning. The Company believes these acti

    4/23/26 8:27:11 AM ET
    $CUEN
    Computer Software: Prepackaged Software
    Technology

    $ACEV
    $ACST
    $ADIL
    $AGRI
    Financials

    Live finance-specific insights

    View All

    Expensify to Announce Q1 2026 Results

    Join Expensify's earnings call on Thursday, May 7th at 2pm PT / 5pm ET. Expensify, Inc. (NASDAQ:EXFY), the easiest way to manage expenses, corporate cards, and travel, today announced that the company's Q1 2026 financial results will be released after market close on Thursday, May 7th, 2026. Expensify will host a call to discuss its Q1 2026 results on Thursday, May 7th, 2026 at 2pm PT / 5pm ET. The link to the call will be available that day on the company's Investor Relations website at investors.expensify.com. Prior to the call, interested parties can visit the website to add the event to their calendars. After the call, the following will be made available at investors.expensify.co

    4/23/26 4:00:00 PM ET
    $EXFY
    Computer Software: Prepackaged Software
    Technology

    SoundHound AI To Report 2026 First Quarter Financial Results, Host Conference Call and Webcast on May 7

    SANTA CLARA, Calif., April 22, 2026 (GLOBE NEWSWIRE) -- SoundHound AI, Inc. (NASDAQ:SOUN), a global leader in voice and conversational AI, today announced that it will report its 2026 first quarter financial results on Thursday, May 7, 2026 after market close. The company will host a conference call and webcast to review the results on the same day. Conference Call and Webcast Information SoundHound AI will host its conference call at 2:00 p.m. PT / 5:00 p.m. ET. A live audio webcast will be available at investors.soundhound.com and a replay will be available at the same location. If you wish to receive company email notifications, please register at https://investors.soundhound.com/i

    4/22/26 4:05:00 PM ET
    $SOUN
    Computer Software: Prepackaged Software
    Technology

    EverCommerce Announces Date of First Quarter 2026 Earnings Call

    DENVER, April 17, 2026 (GLOBE NEWSWIRE) -- EverCommerce Inc. (NASDAQ:EVCM), a leading AI-powered platform helping service SMBs run smarter and grow faster, will report its first quarter 2026 financial results after the U.S. financial markets close on Thursday, May 7, 2026. Management will host a conference call on Thursday, May 7 at 5:00 p.m. Eastern Time / 3:00 p.m. Mountain Time to discuss the Company's financial results and provide a business update. Please visit the "Investor Relations" page of the Company's website (https://investors.evercommerce.com/) for both telephonic and webcast access to this call; a replay will be archived on the website as well. About EverCommerce EverComme

    4/17/26 9:00:00 AM ET
    $EVCM
    Computer Software: Prepackaged Software
    Technology

    $ACEV
    $ACST
    $ADIL
    $AGRI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by LightPath Technologies Inc.

    SC 13G/A - LIGHTPATH TECHNOLOGIES INC (0000889971) (Subject)

    12/13/24 3:18:07 PM ET
    $LPTH
    Semiconductors
    Technology

    Amendment: SEC Form SC 13D/A filed by Reeds Inc.

    SC 13D/A - REED'S, INC. (0001140215) (Subject)

    12/6/24 4:30:32 PM ET
    $REED

    Amendment: SEC Form SC 13D/A filed by Reeds Inc.

    SC 13D/A - REED'S, INC. (0001140215) (Subject)

    12/4/24 6:11:30 AM ET
    $REED

    $ACEV
    $ACST
    $ADIL
    $AGRI
    Leadership Updates

    Live Leadership Updates

    View All

    Kazia Therapeutics Strengthens Scientific Leadership with Appointment of Dr. Sudha Rao as Chief Scientific Officer to Lead Next-Generation Oncology Platform

    SYDNEY, April 15, 2026 /PRNewswire/ -- Kazia Therapeutics (NASDAQ:KZIA), a clinical-stage oncology company developing differentiated therapies for cancers with high unmet need, today announced the appointment of Dr. Sudha Rao as Chief Scientific Officer (CSO). Dr. Rao is the scientific originator of the epigenetic framework underlying paxalisib and a pioneer in next-generation therapeutic platforms, including PD-L1 protein degradation and SETDB1-targeted chromatin modulation. Her appointment brings deep expertise in translational epigenetics, AI-guided epi-drug discovery capability, liquid and spatial epigenetic clinical biomarker precision medicine platforms, and early clinical development

    4/15/26 8:00:00 AM ET
    $KZIA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    LightPath Appoints Two Senior Sales Executives to Drive Defense and Commercial Growth

    Seasoned Defense and Aerospace Executives to Drive Revenue Growth and Expand Market Reach Across LightPath's Defense and Commercial PlatformsORLANDO, Fla., April 8, 2026 /PRNewswire/ -- LightPath Technologies, Inc. (NASDAQ:LPTH) ("LightPath," the "Company," "we," or "our"), a leading provider of next-generation optics and imaging systems for both defense and commercial applications, today announced the appointments of Doug Schoen as Senior Vice President of Global Sales and Ryan Workman as Vice President, Business Development & Product Management, effective April 6, 2026. Both executives bring extensive defense industry leadership experience and will play key roles in accelerating the Compan

    4/8/26 8:31:00 AM ET
    $LPTH
    Semiconductors
    Technology

    The Oncology Institute Names Minh Merchant Chief Legal Officer

    CERRITOS, Calif., April 06, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. ("TOI") (NASDAQ:TOI), one of the largest value-based oncology groups in the United States, today announced that Minh Merchant has joined the organization as Chief Legal Officer. In this role, Ms. Merchant will oversee legal, regulatory, compliance and privacy functions as TOI continues to scale. This role will be essential in enabling the company to continue its growth trajectory while further enhancing its mission to be a trusted healthcare partner to oncology patients and payors. Ms. Merchant has more than two decades of experience advising public and private healthcare organizations, including significant

    4/6/26 9:00:00 AM ET
    $TOI
    Medical/Nursing Services
    Health Care